ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease causing irreversible lung scarring and loss of pulmonary function. IPF Patients suffer from a high rate of pulmonary infections and acute exacerbations of disease that further contribute to pulmonary decline. Low expression of the inducible T-cell costimulatory molecule (ICOS) in peripheral… (More)
DOI: 10.1038/mi.2017.42

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Hrusch2017ICOSPA, title={ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s}, author={Cara L. Hrusch and Stephenie T. Manns and Dana Bryazka and Joshua Casaos and Catherine A Bonham and Mohammad R. Jaffery and Kelly M. Blaine and Kathleen A. Mills and Philip A Verhoef and Ayodeji Adegunsoye and Jesse W Williams and Melissa Y Tjota and Tamson Moore and Mary E. Strek and Imre Noth and Anne I. Sperling}, booktitle={Mucosal Immunology}, year={2017} }